Max Neeman International Adds to Existing Six Sigma, SOP Training
RESEARCH TRIANGLE PARK, N.C., March 27, 2013 /PRNewswire/ — Max Neeman International, a leading Asia-Pacific CRO, has announced successful completion of its first MAXimizer project focused on the Data Management validation process. This project was designed to increase the identification of discrepancies at the first level of data cleaning. A post-training pilot study showed 20% improvement in the performance of level 1 data cleaning, proving MAXimizer to be an excellent quality improvement tool.
MAXimizer is an enterprise wide initiative to empower employees in any department, with problem solving methodology, using various tools and techniques based on the Six Sigma principles. CEO Dr. Ajoy Kumar strongly advocates use of Six Sigma principles in the organization along with global and departmental SOPs, regular internal audits for quality control and client assurance. International Quality Certifications include:
- Quality Management System [ISO 9001:2008]
- Information Security Management System [ISO 27001:2005]
- Management System for Clinical Investigation of Medical Devices [ISO 14155:2001]
- Malcolm Baldrige Performance Excellence Program
Every employee must undergo regular trainings and exposure to the latest developments in their areas of expertise as Max Neeman is a ‘Knowledge Contract Research’ company overall.
Training ranges from technical to non-technical topics of:
- ICH GCP guidelines
- Protocol-specific training
- Regulatory scenario in various Asia-Pac countries
- Project Management workshops
- QA & QC in clinical trials
- Soft skills development workshops
Continuous training and QA/QC procedures have been an integral part of Max Neeman’s corporate culture since operations began in 2001.
About Max Neeman International
Max Neeman International is a leading Asia-Pacific CRO with India expertise and expanded capabilities into N. America and Europe. For over a decade, the company has provided clinical research services for the successful conduct of Phase II-IV drug and device trials to Pharmaceutical, Biotech, Medical Device and Nutraceutical companies in compliance with ICH GCP standards. ‘Max Neeman’ is ISO 9001:2008 certified for monitoring, site management and data management with over >400 employees, 200 active sites in various therapeutic areas and 304 trials awarded. Data Management services alone have touched 60 countries to date. For more information contact Donald Swankie, Vice President USA: email@example.com or go to www.neeman-medical.com.
SOURCE Max Neeman International